What Andrew Huberman actually says about peptides

Watch: the June 2026 episode

"Peptides: The Science, Uses & Safety" with Dr. Abud Bakri, MD, a board-certified internal-medicine physician who treats with peptides. Released June 1, 2026. It runs nearly three hours and is the most rigorous mainstream coverage of BPC-157, GHK-Cu, the pineal peptides, GLP-1s, retatrutide, and the growth-hormone peptides. Worth listening end to end before you buy a single vial.

Source: Huberman Lab - Peptides: The Science, Uses & Safety (Dr. Abud Bakri). For the harder dosing detail he also has a 2024 solo episode.

His three rules, in one breath

Strip away the molecule-by-molecule detail and Huberman keeps returning to the same three ideas. If you remember nothing else, remember these.

• Animal data is not human data. The peptides people are most excited about - BPC-157, epithalon, pinealon - have decades of rat studies and almost no human trials. The glowing testimonials online may be real, or they may be placebo. Nobody has run the trial that would tell us.
• Sourcing is the actual risk. His most-repeated practical warning: if you do this, do it with a board-certified physician and a verified pharmacy. Gray-market vials labeled "not for human consumption" can carry bacterial endotoxin (LPS) that builds up and triggers an inflammatory reaction. There is no reliable third-party testing for most research peptides.
• Growth is a double-edged sword. Peptides that build new blood vessels (BPC-157) or raise growth hormone and IGF-1 (the GH peptides) help healthy tissue and existing tumors alike. Anyone with a cancer history or family risk is the wrong candidate.

What he's said about his own use

Read this carefully: these are things Huberman has described on the podcast about his own experience. One person, no controls, his words paraphrased - not claims about what these peptides do in general, and not a protocol to copy. Your physiology is not his.

The pattern worth noticing: for a category sold on testimonials, he has talked about trying and then coming off most of what he experimented with.

What he says, peptide by peptide

BPC-157 - recovery

The animal data on tendon, ligament, gut, and nerve repair is the most consistent of any repair peptide, and the appeal is obvious. His caution is equally clear: there is essentially no human clinical data, and the mechanism that heals tissue (new blood-vessel growth) is the same one that can feed a tumor. The legal picture also moved - the FDA placed BPC-157 in Category 2 in October 2023, taking it off the free compounding list. Our full BPC-157 breakdown ->

GHK-Cu - skin, hair, recovery

One of the better-characterized peptides on the list. It is a copper-binding tripeptide that drives collagen and tissue remodeling, and the episode covers the topical-plus-red-light-therapy combination for skin. Lower-risk than the growth peptides; copper accumulation is the thing to watch. Our full GHK-Cu breakdown ->

The growth-hormone peptides - CJC-1295, ipamorelin, sermorelin, tesamorelin, MK-677

This is the cluster he is hardest on. They all raise growth hormone and IGF-1, which promotes growth indiscriminately - including tumors - and can cause fluid retention, insulin resistance, and joint and skeletal changes over time. His specific call on CJC-1295 is to avoid it outright, citing a death during a clinical trial - though the trial's physician attributed that death to pre-existing heart disease, not the drug. He frames ipamorelin as the cleaner half of the common stack but still a GH drug. His blanket rule: if you are under 30, there is rarely a reason to push growth hormone at all, and over 30 it is a physician-supervised, cancer-screened, minimal-dose decision.

GLP-1s and retatrutide - weight loss

Here the tone flips. These are real, heavily studied drugs, and the episode treats them seriously - while flagging under-studied long-term cognitive and fertility effects and the muscle-mass loss that comes with rapid weight loss. The standout warning is on sourcing: there is no reliable third-party testing for gray-market versions, so for genuinely pure retatrutide you currently have to go through the manufacturer. The approved GLP-1s - semaglutide and tirzepatide - are the studied, prescribable versions of this class.

TB-500 (Thymosin beta-4) - recovery

The common stack partner to BPC-157. He notes it is a synthetic version of a protein the thymus makes in childhood, focused on tissue repair, and that because it does not touch the growth-hormone pathway it is generally framed as lower tumor risk than the GH peptides. Still no human trials. Our full TB-500 breakdown ->

Thymosin Alpha-1 - immunity

Tied in the episode to thymus involution - the gland that runs your immune training shrinks with age. Thymosin Alpha-1 is the immune-modulating peptide here, and it has more real-world clinical precedent than the repair peptides (it is an approved drug in several countries). The episode pairs it with using blood tests and immune-cell counts to actually measure thymic health. Our full Thymosin Alpha-1 breakdown ->

Epitalon and pinealon - longevity and sleep

The pineal peptides from Russian gerontology. Epitalon is pitched for telomere and circadian effects; pinealon for sleep and cognition. The animal and longevity logic is internally consistent, but Huberman is explicit that there are no clinical trials pointing to a dose that extends human life. His own pinealon REM result was striking - and he still stopped.

PT-141 and the melanotan family - libido and tanning

These act on the melanocyte-stimulating-hormone pathway. PT-141 (bremelanotide) is FDA-approved for low desire in premenopausal women and used off-label by men; the melanotans drive tanning and, in the brain-penetrating versions, libido and appetite changes. The shared caution: they stimulate melanocytes, so anyone with melanoma risk should steer clear, and they can raise blood pressure and cause nausea.

His one piece of universal advice: sourcing

If the episode has a single takeaway that applies to every peptide, it is this. The molecule is rarely the first problem - the supply chain is. He implores listeners to work with a board-certified physician and acquire peptides through a reliable source, because gray-market and black-market product can carry endotoxin contamination that accumulates to a dangerous tipping point, and "not for human consumption" labeling means nobody is checking purity. For the newest weight-loss molecule, retatrutide, his point is blunter: there is no trustworthy third-party testing, so pure product means the manufacturer, full stop.

This is the same standard Protocol One uses: a compounding pharmacy that provides a Certificate of Analysis per peptide, or a vendor with real third-party batch testing. No COA, no buy.

Who he thinks should and shouldn't

Probably shouldn't: anyone under 30 chasing growth hormone with no clinical reason; anyone with cancer history or risk (especially for BPC-157, the GH peptides, and the melanocortin peptides); and anyone unwilling to use a knowledgeable physician and a verified source.

Might consider, with guardrails: adults over 30, supervised by a board-certified physician, with baseline cancer screening and hormone monitoring, the minimum effective dose, cycled rather than run continuously, and a verified pharmaceutical or compounding source.

Huberman on peptides - FAQ

Does Andrew Huberman recommend peptides?

Not broadly. Huberman's position is cautious. He explains the science and the appeal, but his throughline is that most peptides have strong animal data and almost no human trials, that sourcing is the main danger, and that anything driving tissue growth carries a tumor risk. He repeatedly says that if you explore peptides you should do it with a board-certified physician and a verified source - and he has personally stopped taking most of the ones he tried.

What peptides does Andrew Huberman take?

By his own account on the podcast, fewer than people assume. He has described trying and then discontinuing BPC-157 (now FDA-restricted), sermorelin (which he has said affected his sleep and, by his account, his PSA reading), and pinealon (despite describing a notable improvement in his REM sleep). He tried MK-677 once and disliked it, saying it disrupted his sleep. The net picture he paints is someone who has cycled off nearly everything he experimented with.

What does Huberman say about BPC-157?

He finds the animal data on tissue repair genuinely interesting but stresses there is essentially no human clinical data, so widespread use is experimental. His main safety point is that BPC-157 drives angiogenesis (new blood-vessel growth), which could feed an existing tumor, so anyone with cancer history or risk should avoid it. He also notes that the FDA moved BPC-157 off the permitted compounding list (Category 2) in October 2023, which changed how it can legally be obtained.

What does Huberman say about CJC-1295?

He recommends against it. He has said he cannot see why anyone would use CJC-1295, citing fluid retention and a death during a clinical trial (which the trial's physician attributed to pre-existing heart disease, not the drug). More broadly he warns that growth-hormone-promoting peptides raise IGF-1, which indiscriminately promotes tissue growth including tumors, and that people under 30 have little reason to augment growth hormone at all.

Does Huberman take GLP-1s or retatrutide?

The June 2026 episode covers GLP-1s (the semaglutide and tirzepatide class) and retatrutide as legitimate, heavily studied drugs, while flagging under-studied long-term physical, cognitive, and fertility effects and muscle-mass loss. The sharpest practical warning is on sourcing: there is no reliable third-party testing for gray-market peptides, so for genuinely pure retatrutide you currently have to get it from the manufacturer, Eli Lilly.

Is BPC-157 still legal in 2026?

BPC-157 is not FDA-approved for human use and is not on the banned-substances list. In October 2023 the FDA placed it in Category 2 of its bulk-substances review, which removed it from the list compounding pharmacies may freely use. It is still sold by research-chemical vendors labeled "not for human consumption," which is the unregulated gray zone. The legal route is a licensed physician working with a compliant pharmacy. Status is changing - verify before you act.

Where to go next

If you want the foundations:

• What are peptides - the plain-English starting point
• How peptides actually work - half-life, injection vs oral, why selectivity is the whole game
• The Tier List - all our peptides ranked S / A / B / Watch with rationale

If you want the peptides Huberman covers:

• BPC-157 · TB-500 · GHK-Cu - recovery and skin
• CJC-1295 · Ipamorelin - the growth-hormone peptides he is cautious on
• Semaglutide · Tirzepatide · Retatrutide - the GLP-1 class
• PT-141 · Thymosin Alpha-1 · Epitalon · Pinealon

If you want to figure out which one fits you:

• Which peptide is right for you? - the 11-question master quiz
• The 60-peptide cheat sheet, audited - the whole field